We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Aldagen Announces FDA Clearance of IND to Begin Phase 2 Study in Ischemic Stroke

News   Jan 05, 2011

 
Aldagen Announces FDA Clearance of IND to Begin Phase 2 Study in Ischemic Stroke
 
 
Advertisement
 

RELATED ARTICLES

What the Embryo Can Teach Us About Cell Reprogramming

News

Researchers have been studying early embryos to find clues which might lead them to a more efficient and faster generation of high-quality, fully reprogrammed stem cells.

READ MORE

Controlled Human Infection Models for SARS-CoV-2 Vaccine Development

News

Infecting some volunteers with COVID-19 may provide valuable insights for future rounds of vaccine testing, but would require very strict controls, argues a group of infectious disease experts in the New England Journal of Medicine.

READ MORE

Quick and Simple Technology Enhances the Potential of Stem Cells To Differentiate Into Adult Cells

News

Researchers have developed a new, simple and fast technology that enhances in vitro and in vivo the potential of stem cells to differentiate into adult cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE